Create Free Account

By creating account you will get access to hot stocks & personalised emails

Oceania Healthcare Ltd

Healthcare AU OCA

0.5AUD
-0.02(3.85%)

Last update at 2024-05-14T00:06:00Z

Day Range

0.500.51
LowHigh

52 Week Range

0.500.78
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax 12.00M 56.25M 75.14M 31.80M 75.88M
Minority interest - - - - -
Net income 15.45M 61.13M 85.53M 45.37M 76.97M
Selling general administrative 164.64M 158.94M 115.69M 127.33M 122.36M
Selling and marketing expenses - - - - -
Gross profit 247.18M 231.14M - 186.98M 180.05M
Reconciled depreciation 17.92M 18.62M - 14.49M 9.54M
Ebit 35.44M 70.39M -4.01280M 49.98M 77.58M
Ebitda 53.36M 89.01M - 59.52M 86.42M
Depreciation and amortization 17.92M 18.62M - 9.54M 8.84M
Non operating income net other - - - - -
Operating income 35.44M 70.39M 3.67M -20.29800M 2.38M
Other operating expenses 247.62M 236.72M 56.91M 213.94M 184.60M
Interest expense 13.87M 8.85M 0.00000M 3.00M 2.94M
Tax provision -3.44800M -4.87900M -10.39600M -14.66600M -13.57600M
Interest income 1.76M 0.08M 73.68M 28.92M 43.33M
Net interest income -12.55600M -9.30300M - -5.10600M -2.85200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.44800M -4.87900M -12.47520M -13.57600M -1.09600M
Total revenue 247.18M 231.14M 175.42M 186.98M 180.05M
Total operating expenses 247.62M 236.72M - 184.60M 151.43M
Cost of revenue - - - - 123.75M
Total other income expense net -23.43900M -14.14100M - 32.91M 50.03M
Discontinued operations - - - - -
Net income from continuing ops 15.45M 61.13M - -13.64200M 45.37M
Net income applicable to common shares 15.45M 61.13M 102.82M -13.64200M 45.37M
Preferred stock and other adjustments - - - - -
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Total assets 2544.94M 2197.69M 1883.73M 1548.70M 1147.15M
Intangible assets 3.55M 3.67M 5.23M 4.26M 0.58M
Earning assets - - - - -
Other current assets 101.65M 6.61M 2.00M 1.40M 1.37M
Total liab 1582.68M 1248.85M 1048.53M 953.48M 610.06M
Total stockholder equity 962.26M 948.84M 835.20M 595.21M 537.10M
Deferred long term liab - - - - -
Other current liab 969.17M 814.70M 623.78M 535.37M 392.32M
Common stock 713.37M 705.29M 675.62M 588.39M 579.50M
Capital stock 713.37M 705.29M - 588.39M 580.79M
Retained earnings -68.49600M -54.73500M -86.98300M -155.90700M -127.89900M
Other liab 66.87M 65.07M 60.12M 51.00M 56.67M
Good will 3.17M 4.93M 5.34M 6.57M 16.82M
Other assets 1597.72M 1378.55M 1099.80M 947.80M 881.67M
Cash 7.44M 9.74M 79.91M 17.62M 18.29M
Cash and equivalents - - - - -
Total current liabilities 1024.29M 858.81M 647.22M 615.03M 420.07M
Current deferred revenue 45.33M 42.07M - 34.34M 21.92M
Net debt 550.95M 380.29M - 320.83M 151.25M
Short term debt - - - 39.46M 2.06M
Short long term debt - - - - 2.44M
Short long term debt total 558.39M 390.03M 327.29M 338.45M 169.54M
Other stockholder equity 317.38M 298.29M 244.98M 162.73M 139.15M
Property plant equipment 716.46M 727.73M 645.99M 530.81M 442.71M
Total current assets 224.05M 82.80M 127.90M 59.25M 70.63M
Long term investments 1597.72M 1378.55M - 947.80M 881.67M
Net tangible assets 955.54M 940.24M 825.16M 584.38M 601.21M
Short term investments - - - 66.13M 126.11M
Net receivables 106.47M 66.45M 43.10M 40.23M 30.93M
Long term debt 553.59M 380.14M 327.29M 325.45M 264.64M
Inventory - - - -0.02700M 20.04M
Accounts payable 9.79M 2.04M 9.30M 5.86M 3.77M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 317.38M 298.29M - 162.73M 85.50M
Additional paid in capital - - - - -
Common stock total equity - - - 588.39M 580.79M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 40.82M 1333.05M
Deferred long term asset charges - - - - -
Non current assets total 2320.89M 2114.89M - 1489.44M 1076.52M
Capital lease obligations 4.80M 9.89M - 13.00M 5.52M
Long term debt total - - 327.29M 325.45M 268.56M
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -219.60100M -218.82000M - -135.98300M -153.77400M
Change to liabilities 11.33M -1.75700M 7.29M 0.09M 4.69M
Total cashflows from investing activities -219.60100M -218.82000M -122.62800M -135.98300M -153.77400M
Net borrowings 171.07M 44.22M -1.65600M 54.31M 96.68M
Total cash from financing activities 147.09M 43.13M 82.22M 31.48M 56.59M
Change to operating activities - - - - -
Net income 15.45M 61.13M 102.82M -13.64200M 45.37M
Change in cash -2.30600M -70.16100M 74.74M -5.13800M 7.43M
Begin period cash flow 9.74M 79.91M 17.62M 22.76M 10.86M
End period cash flow 7.44M 9.74M 79.91M 17.62M 18.29M
Total cash from operating activities 15.45M 18.62M 115.14M 99.37M 89.32M
Issuance of capital stock - 20.00M - - 1.30M
Depreciation 17.27M 18.62M 16.03M 14.49M 9.54M
Other cashflows from investing activities - - -66.00500M -95.51600M -80.87900M
Dividends paid -21.80600M -19.41800M 7.56M -22.22700M -12.73200M
Change to inventory - - - - -
Change to account receivables 5.64M 13.11M -2.72520M -2.59500M 0.29M
Sale purchase of stock - - - 1.30M 1.30M
Other cashflows from financing activities 223.19M 158.02M -4.56000M 166.33M 117.20M
Change to netincome 19.86M 14.43M -8.47920M 101.02M 29.42M
Capital expenditures 55.16M 56.29M 43.42M 40.43M 33.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - -56.24800M -59.42400M -44.91200M
Stock based compensation - - - - -
Other non cash items -15.44800M -79.74900M - -0.85000M -54.91500M
Free cash flow -39.71200M -37.66900M - -40.43300M -33.38900M

Fundamentals

  • Previous Close 0.52
  • Market Cap382.23M
  • Volume1982
  • P/E Ratio26.00
  • Dividend Yield4.01%
  • EBITDA13.18M
  • Revenue TTM260.35M
  • Revenue Per Share TTM0.36
  • Gross Profit TTM 85.03M
  • Diluted EPS TTM0.02

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OCA
Oceania Healthcare Ltd		 -0.02 3.85% 0.50 26.00 - 1.63 0.43 4.00 22.56
RHCPA
Ramsay Health Care Ltd Pref		 -0.11 0.10% 106.50 65.12 - 0.90 - - -
RHC
Ramsay Health Care Ltd		 0.51 1.00% 51.30 55.29 23.81 0.75 2.61 1.45 12.91
SNZ
Summerset Group Holdings Ltd		 0.14 1.54% 9.22 5.72 - 9.08 1.03 13.66 7.94
REG
Regis Healthcare Ltd		 0.06 1.49% 4.08 - 24.57 1.34 256.72 4.74 6.26

Reports Covered

Stock Research & News

View All

Profile

Oceania Healthcare Limited, together with its subsidiaries, owns and operates various care centers and retirement villages in New Zealand. The company operates in three segments: Care Operations, Village Operations, and Other. It provides rest home, hospital, and dementia; independent living and rental properties for retirement villages; accommodation, care, and related services to aged care residents; and support services, including administration, marketing, and operations. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.

Oceania Healthcare Ltd

Deloitte Building, Auckland, New Zealand, 1010

Key Executives

Name Title Year Born
Mr. Brent Pattison BBS, C.A. Chief Exec. Officer NA
Ms. Kathryn Waugh Chief Financial Officer NA
Anita Hawthorne B.Com., C.A. Group Gen. Mang. of Sales & Services NA
Dr. Frances Hughes Gen. Mang. - Nursing & Clinical Strategy NA
Eli Parkin Head of Devel. NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA
Eli Parkin Head of Development NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.